Patent · US Active

Substituted nucleosides, nucleotides and analogs thereof

US10370401B2 · kind B2 · utility

16Cited by
8References
41Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 23, 2017
Grant dateAug 6, 2019
Priority date
Expiry dateOct 23, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a Picornavirus and/or Flaviviridae infection with one or more nucleosides, nucleotides and nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.